A Post-Market Domestic (US) and International Data Collection to Assess the Truliant Knee System
ConditionKnee Arthroplasty, Total
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorExactech
About this trial
A Post-Market Domestic (US) and International Data Collection to Assess the Truliant® Knee System
Eligibility criteria
Qualifiers
Subjects who agree to participate in the study that have not had surgery prior to being enrolled in the study.
Skeletally mature (18 years of age or older).
Subject is willing and able to provide written informed consent for participation in the study.
Subject is to receive a Truliant® total knee replacement for Osteoarthritis, Avascular Necrosis, Rheumatoid Arthritis, Post-Traumatic Arthritis, Polyarthritis, Primary Implantation Failure, or as a Conversion of Uni-Compartmental Knee.
Disqualifiers
Gender
Age at surgery
Height/Weight
Indication for surgery
Trial design
Treatments tested in this trial
- Truliant Total Knee System
Treatment groups
1,000 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov